8 Best Small-Cap Growth Stocks to Buy According to Analysts
During the third quarter of 2024, small-cap stocks represented by the Russell 2000 Index made a strong comeback after a somewhat disappointing second quarter.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 32,769,186 | $215,948,936 | +17% | 1.97% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | Large Shareholder | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | Large Shareholder | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | Large Shareholder | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | Large Shareholder | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | Large Shareholder | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.72 | 11,447 | Director | 7,077,560 | 2024-10-29 | Filing | |
| $6.31 | 6,000 | Officer | 521,138 | 2024-10-24 | Filing | |
| $6.67 | 11,447 | Director | 7,089,007 | 2024-10-15 | Filing | |
| $6.36 | 15,000 | Officer | 1,450,881 | 2024-10-09 | Filing | |
| $6.32 | 15,000 | Officer | 1,426,506 | 2024-10-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,179,504 | $238,409,910 | 0.19% | |
| 2. | 15,665,210 | $154,458,970 | 0% | |
| 3. | 12,985,927 | $128,041,240 | 0.43% | |
| 4. | 12,393,872 | $122,203,576 | 0% | |
| 5. | 12,151,646 | $119,815,230 | 0% |
News See All
10 Worst ARK Stocks To Buy According To Short Sellers
Investing comes in all sizes and flavors. For the risk averse investors that are looking for steady payouts or long term stability, value and dividend paying stocks are the way to go.
10 Best Medical AI Companies
Generally, when you hear the term "artificial intelligence," your mind jumps straight to semiconductor and big tech companies that have been making huge profits as a result of the AI boom.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2024 Earnings Call Transcript
Chris Gibson: Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, delighted to be joining you on our L(earnings) today.
Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant's chips and technology for drug discovery.
7 Best Under-The-Radar AI Stocks Hedge Funds are Buying
The AI-led stock rally that rewarded mega-cap technology stocks has finally started to trickle down to other industry players that were seemingly not related to the AI and tech industry.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q1 2024 Earnings Call Transcript
Chris Gibson: Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I'm so delighted you've joined us today for our Q1 2024 Earnings Call -- L(earnings) Call, as we call it.
Jim Cramer is Recommending These 10 Stocks Heading Into May 2024
In this article, we will take a detailed look at the latest stocks Jim Cramer is recommending.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2023 Earnings Call Transcript
Chris Gibson: Hi, everybody. I’m Chris Gibson, Co-Founder and CEO of Recursion, and I am really excited to welcome you to our first ever Learnings Call here at Recursion.
Cathie Wood Was Buying These 5 Stocks for 2024
Cloud-based restaurant management software company Toast Inc (NYSE:TOST) ranks fifth in our list of the top Cathie Wood stock picks in 2024.
Billionaire Hedge Funds
